Status:
UNKNOWN
Sensitivity Evaluation of Serological Tests for Covid-19
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
The primary objective of this study is to test the diagnostic sensitivity of antibody tests for the diagnosis of SARS-CoV2 infection, available to clinical laboratories, within a national network of h...
Eligibility Criteria
Inclusion
- All patients or individuals exposed to Sars-Cov2 Infection.
Exclusion
- There are no criteria for excluding patients or individuals, if not the refusal to participate to project
Key Trial Info
Start Date :
November 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT04678024
Start Date
November 18 2020
End Date
November 1 2021
Last Update
December 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Galeazzi
Milan, Italy, 20161